Britannia has ~32% market share in biscuits, which we expect to gradually move up by ~100 basis points every year…
Estimates down 1-2%, with forecasts cut for Europe even as India numbers get upgrade; TP up to Rs 225 from…
GST-driven price cuts are likely to sustain volume growth and provide a buffer against input cost inflation; TP rises to…
EPS estimates up 2% on account of strong growth in advertising, which should be sustained; TP up to Rs 650,…
Sun Pharma’s near-term key event is Halol inspection. Halol reinspection in Q4FY18 could unlock several key filings. We increase target…
Sectoral growth, carrier’s superior positioning and attractive valuations behind initiation with ‘Outperform’ and TP of Rs 1,650
Scalable model with proven appetite to use high FCF to push growth; initiated with ‘Outperform’ and TP of Rs 770
HZL is fully valued; there’s 60% upside from other verticals; coverage initiated with ‘Outperform’ and target price of Rs 345
S Chand has a 2% share in a fragmented market. K-12 formed 80% of its FY17 revenue, and higher education…
Eris is a pure play in the India pharma market, with presence in the fast-growing and high-entry-barrier cardiac and diabetes…
At a time when global household wealth grew by $16.7 trillion to $280 trillion in 2016-17, up 6.4%, household wealth…
As Coal India ramps up production, this may reverse. Jewellery and textiles drove the export disappointment: Some decline in jewellery…
DBL is targeting Rs 80-100 billion of orders in FY18E (vs Rs 120 billion in FY17). However, we build Rs…
Post recapitalisation, we expect PSU banks to target growth, with initial bias to cut rates. This has implications for NBFCs…
Bharti reported a 5/8% beat on Ebitda/adjusted net profits, respectively, for the Sep-17 quarter. 60% of Ebitda beat came from…
We recently met with Maruti management and came back quite positive on the near-term outlook with expectations of a strong…
Tata Global Beverages, a global beverages company with multiple brands: It owns tea, coffee, and other beverage brands globally, with…
TP revised to Rs 460 from Rs 360 given positive outlook on growth and reasonable valuations with clear balance sheet…
